Royal Philips (PHG) is showcasing its latest solutions in cardiology at the Transcatheter Cardiovascular Therapeutics, TCT, annual meeting. “With many exciting advancements on the horizon in cardiology, Philips is looking forward to connecting with our customers and partners at TCT and showcasing our latest suite of AI-enabled imaging systems, smart therapeutic and diagnostic devices, software, and services in integrated solutions,” said Stacy Beske, Business Leader for Image Guided Therapy Devices at Philips. “As a long-standing leader in the space, we are committed to harnessing the latest science and technology and working in collaboration with physicians to deliver best-in-class solutions to enhance patient care.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PHG:
- Philips upgraded to Outperform from Neutral at Oddo BHF
- Philips, Siloam Hospitals Group sign AI capability MoU
- Philips price target raised to EUR 28.50 from EUR 26.50 at Citi
- Philips, Jackson Health System announces results of collaborative LCA
- Philips announces FDA approval for enhance LumiGuide guidewire
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
